Mark W. Logue, Ph.D.
Statistician, National Center for PTSD, VA Boston Healthcare System Associate Professor, Psychiatry, BUSM Research Assistant Professor,
Dept of Medicine (Biomedical Genetics), BUSM
2001-2002 NIMH Post-Doctoral Research Fellow, Psychiatry, University of Iowa, Iowa City IA.
2001 – PhD Statistics – University of Iowa, Iowa City IA.
1996 – MS in Statistics – University of Iowa, Iowa City IA.
1994 – BS in Mathematics – University of Oregon, Eugene OR.
My research involves the use of computational tools to search the human genome for genetic variants influencing risk of psychiatric and neurological disorders including panic disorder, post-traumatic stress disorder, and Alzheimer’s disease. The genetics of these traits is complex, as multiple genes interact with environmental factors to determine an individual’s risk. When studying psychiatric traits, this complexity is compounded because psychiatric disorders are not distinct at the genetic level. For example, genetic variants that increase risk of developing panic disorder may also predispose an individual to bipolar disorder or phobias. To unravel this complexity, information must be integrated from a variety of sources, including families with a multiple affected individuals, large case-control study samples, and samples from different ancestral populations. The type of genetic data that can be examined is similarly diverse and can include microsatellite markers, single nucleotide polymorphisms, and base-pair level sequence data. By leveraging these multiple sources of data, and by using analysis methods that allow for this complexity at both the genetic and trait level, the presence of disease can be correlated with variants across multiple genes. The identification of these variants can implicate new biological systems or molecular pathways which are disrupted, potentially resulting in the development of new biomarkers of disease, new treatments, or personalized therapies based on a patient’s genetic profile.
Logue MW, Smith AK, Baldwin C, Wofl EJ, Guffanti G, Ratanatharathorn A, Stone A, Schichman SA, Humphries D, Binder EB, Arloth J, Menke A, Uddin M, Wildman D, Galea S, Aiello AE, Koenen KC, Miller MW. 2015. An analysis of gene expression in PTSD implicates genes involved in the glucocorticoid receptor pathway and neural responses to stress. Psychoneuroendocrinology. 57:1-13. PMCID: PMC4437870
Logue MW, Amstadter AB, Baker DG, Duncan L, Koenen KC, Liberzon I, Miller MW, Morey RA, Nievergelt CM, Ressler KJ, Smith AK, Smoller JW, Stein MB, Sumner JA, Uddin M. 2015. The Psychiatric Genomics Consortium Posttraumatic Stress Disorder Workgroup: Posttraumatic stress disorder enters the age of large-scale genomic collaboration. Neuropsychopharmacology. 40(10):2287-97. PMCID: PMC4538342
Logue MW, Schu M, Vardarajan B, Farrell J, Bennett DA, Buxbaum JD, Byrd GS, Ertekin-Taner N, Evans D, Foroud T, Goate A, Graff-Radford NR, Kamboh MI, Kukull WA, Manly JJ, Alzheimer Disease Genetics Consortium, Haines JL, Mayeux R, Pericak-Vance MA, Schellenberg GD, Lunetta KL, Baldwin CT, Fallin MD, Farrer LA. 2014. Two rare AKAP9 variants are associated with Alzheimer disease in African Americans. Alzheimer and Dementia 10(6):609-618.e11. PMCID: PMC4253055.
Logue MW, Schu MS, Vardarajan BN, Farrell J, Lunetta LK, Jun G, Baldwin CT, DeAngelis MM, Farrer LA, 2014. A search for AMD risk variants in Alzheimer disease genes and pathways. Neurobiology of Aging. 35(6):1510.e7-1510.e18. PMCID: PMC3961547
Logue MW, Solovieff N, Leussis MP, Wolf EJ, Melista E, Baldwin C, Koenen KC, Petryshen T, Miller MW. 2013. The ankyrin-3 gene is associated with posttraumatic stress disorder and externalizing comorbidity. Psychoneuroendocrinology 38(10), 2249-2257. PMCID: PMC3775967
Logue MW, Baldwin C, Guffanti G, Melista E, Wolf EJ, Reardon AF, Uddin M, Wildman D, Galea S, Koenen KC, Miller MW. 2013. A genome-wide association study of post-traumatic stress disorder identifies the retinoid-related orphan receptor alpha (RORA) gene as a significant risk locus. Molecular Psychiatry. 18, 397-342. PMCID: PMC3494788.
Reitz C, Jun G, Naj A, Rajbhandary R,Vardarajan B, Wang L, PhD; Valladares O, Lin C, Larson EB, Graff-Radford NR, Evans D, MD; Philip L. De Jager PL, MD, PhD; Crane PK, MD, MPH; Buxbaum JD, Murrell JR, Raj T, Ertekin-Taner N, Logue M, Baldwin CT, Green RC, MD, MPH; Barnes LL, Cantwell LB, Fallin MD, Go RCP, Griffith P, Obisesan TO, Manly JJ, Lunetta KL, Kamboh MI, Lopez OL, Bennett DA, Hendrie H, Hall KS, Goate AM, Byrd GS, Kukull WA, Foroud TM, Haines JL, Farrer LA, Pericak-Vance MA, Schellenberg GD, Mayeux R, for the Alzheimer Disease Genetics Consortium. 2013. Variants in the ATP-Binding Cassette Transporter (ABCA7), Apolipoprotein E ϵ4,and the Risk of Late-Onset Alzheimer Disease in African Americans. JAMA. 309(14):1483-1492. PMCID: PMC3667653.
Logue MW, Schu, M, Vardarajan BN, Buros, J, Green RC, Go RCP, Griffith, P, Obisesan, TO, Shatz R, Borenstein A, Cupples, LA, Lunetta KL, Fallin MD, Baldwin CT, Farrer LA. 2011. A Comprehensive Genetic Association Study of Alzheimer Disease in African Americans. Archives of Neurology, 68:1569-1579. PMCID: PMC3356921.